Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ozempic
Ozempic
Are weight loss drugs a win for the global economy?
Pharma Voice
Thu, 08/31/23 - 10:14 am
Novo Nordisk
Wegovy
weight loss
Ozempic
Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says
Fierce Pharma
Mon, 08/28/23 - 08:00 pm
Novo Nordisk
weight loss
Wegovy
Ozempic
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print
Forbes
Mon, 08/21/23 - 10:38 am
weight loss
Novo Nordisk
Wegovy
Ozempic
Demand for weight loss drugs soars to nearly half of Americans
Pharma Voice
Wed, 08/16/23 - 10:14 am
weight loss
Novo Nordisk
Ozempic
In the era of blockbuster obesity drugs, a personalized approach could boost outcomes
Pharma Voice
Wed, 08/9/23 - 10:14 am
obesity
Phenomix
Novo Nordisk
Ozempic
Wegovy
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines
Fierce Pharma
Thu, 08/3/23 - 06:44 pm
Novo Nordisk
Eli Lilly
Mounjaro
Ozempic
legal
side effects
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
Motley Fool
Wed, 08/2/23 - 10:16 am
Ozempic
Novo Nordisk
weight loss
diabetes
Why Novo Nordisk Stock Thrashed the Market on Monday
Motley Fool
Mon, 07/31/23 - 09:52 pm
Novo Nordisk
Ozempic
share repurchase
Stomachs freeze up with Ozempic in rare side effect
Beckers Hospital Review
Wed, 07/26/23 - 09:54 am
Novo Nordisk
Ozempic
side effects
gastroparesis
European regulators probe suicide risk to Ozempic, other Novo drug Saxenda
BioPharma Dive
Mon, 07/10/23 - 09:40 pm
Novo Nordisk
Ozempic
Saxenda
EMA
Europe
suicide
Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher
Motley Fool
Thu, 07/6/23 - 11:17 am
Novo Nordisk
Ozempic
obesity
diabetes
weight loss
addiction
Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Motley Fool
Mon, 07/3/23 - 10:37 am
Pfizer
obesity
lotiglipron
danuglipron
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
Yahoo/Reuters
Thu, 06/22/23 - 10:21 am
Novo Nordisk
EMA
semaglutide
Ozempic
Wegovy
thyroid cancer
obesity
diabetes
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
CNBC
Tue, 06/20/23 - 09:54 pm
Novo Nordisk
legal
Ozempic
Wegocy
knockoffs
More payers could stanch off-label use of Ozempic
Medical Marketing and Media
Mon, 06/19/23 - 10:24 am
Novo Nordisk
Ozempic
off-label
weight loss
This Biotech Is Developing The Next Ozempic
Motley Fool
Fri, 06/16/23 - 10:11 am
Structure Therapeutics
diabetes
obesity
Ozempic
Akero’s NASH drug combined with Ozempic cut liver fat in small study
Stat
Mon, 06/5/23 - 10:10 am
Akero Therapeutics
efruxifermin
NASH
Ozempic
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Mon, 06/5/23 - 10:07 am
Pfizer
danuglipron
Novo Nordisk
Ozempic
weight loss
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »